Seizure activity is increased in endocrine states characterized by decline in endogenous levels of the neurosteroid 3α,5α-THP

Neuroendocrinology

Volumn 68, Issue 4, 1998, Pages 272-280

  Frye, Cheryl A ^a,b   Bayon, Laura E ^a  

^a The Holleran Center for Community Action and Public Policy   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

amino butyric acid; Estrous cycle; Gonadal steroids; Kainic acid; Lordosis; Neurosteroid; Pregnancy; Seizure

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; FINASTERIDE; KAINIC ACID; NEUROSTEROID; OXIDOREDUCTASE; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DIESTRUS; ESTRUS; FEMALE; METESTRUS; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROESTRUS; PROGESTERONE BLOOD LEVEL; PROGESTERONE METABOLISM; RAT; SEIZURE; SEIZURE THRESHOLD; SUBCUTANEOUS DRUG ADMINISTRATION; TONIC CLONIC SEIZURE;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CORPUS LUTEUM; ENDOCRINE SYSTEM; ESTRUS; FEMALE; FINASTERIDE; INJECTIONS, SUBCUTANEOUS; ISOMERISM; KAINIC ACID; POSTPARTUM PERIOD; PREGNANCY; PREGNANOLONE; PROGESTERONE; RATS; RATS, LONG-EVANS; SEIZURES; TIME FACTORS;

EID: 0031696071     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054375     Document Type: Article

References (50)

1. Selye H: The antagonism between anesthetic steroid hormones and pentamethylenetetrazol (metrazol). J Lab Clin Med 1942;27:1051-1053.
2. Roof RL, Duvdevani R, Braswell L, Stein DG: Progesterone facilitates cognivite recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp Neurol 1994;129:64-69.
3. Roof RL, Duvdevani R, Stein DG: Gender influences outcome of brain injury: Progesterone plays a protective role. Brain Res 1993; 607:333-336.
4. Backstrom T: Epileptic seizures in women related to plasma estrogen and progesterone during the menstural cycle. Acta Neurol Scand 1976;54:321-347.
5. Duncan S, Read CL, Brodie MJ: How common is catamenial epilepsy? Epilepsia 1993;34:827-831.
6. Jacono JJ, Robertson JM: The effects of estrogen, progesterone and ionized calcium on seizures during the menstrual cycle of epileptic women. Epilepsia 1987;28:571-577.
7. Rosciszewska D, Buntner B, Guz I, Zawisza L: Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy. J Neurol 1986;49:47-51.
8. Zimmerberg B, Morrow AL: The role of neurosteroids in alcohol-related behaviors: New studies from the laboratory and clinic. Symposium 1996.
9. Bonuccelli U, Melis GB, Paoletti AM, Fioretti P, Murri L, Muratorio A: Unbalanced progesterone and estradiol secretion in catamenial epilepsy. Epilepsy Res 1989;3:100-106.
10. Narbone MC, Ruello C, Oliva A, Baviera G, D'Amico D, Bramanti P, Di Perri R: Hormonal disregulation and catamenial epilepsy. Funct Neurol 1990;5:49-53.
11. Chia KV, Scarffe RJ: Catamenial epilepsy. Aust NZ J Obstet Gynaecol 1993;33:93-94.
12. Herzog AG: Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders. Neurology 1986;36:1607-1610.
13. Belelli D, Bolger MB, Gee KW: Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Eur J Pharmacol 1989;166: 325-329.
14. Finn DA, Gee KW: The estrus cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid. J Pharmacol Exp Ther 1994;271:164-170.
15. Frye CA: The neurosteroid 3α,5α-THP has anti-seizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res 1995;696:113-120.
16. Wilson MA: Influences of gender, gonadectomy, and estrous cycle on GABA/BZ receptors and benzodiazepine responses in rats. Brain Res Bull 1992;29:165-172.
17. Tauboll E, Lindstrom S: The effect of progesterone and its metabolite 5α-pregnan-3α-ol-20-one on focal epileptic seizures in the cat's visual cortex in vivo. Epilepsy Res 1993;14:17-30.
18. Holzbauer M: Physiological variations in the ovarian production of 5α-pregnane derivatives with sedative properties in the rat. J Steroid Biochem 1975;6:1307-1310.
19. Holzbauer M: In vivo secretion of 3α-hydroxy-5α-pregnan-20-one, a potent anesthetic steroid, by the adrenal gland of the rat. J Steroid Biochem 1985;22:97-102.
20. Paul SM, Purdy RH: Neuroactive steroids. FASEB J 1992;6:2311-2322.
21. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM: Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986;232:1004-1007.
22. Frye CA, Scalise T: Pregnane neurosteroids have anti-seizure effects in kainic acid and perforant pathway stimulation models of epilepsy. Epilepsia 1998;submitted.
23. Karavolas HJ, Herf SM: Conversion of progesterone by rat medial basal hypothalamus tissue to 5α-pregnane-3,20-dione. Endocrinology 1971;89:940-942.
24. Karavolas HJ, Hodges DR: Neuroendocrine metabolism of progesterone and related progestins. Ciba Found 1990;153:22-55.
25. Jung-Testas I, Hu ZY, Baulieu EE, Robel P: Neurosteroids: Biosynthesis of pregnenolone and progesterone in primary cultures of rat glial cells. Endocrinology 1989;125:2083-2091.
26. Gallo MA, Smith SS: Progesterone withdrawal decreases latency to and increases duration of electrified prod burial: A possible rat model of PMS anxiety. Pharmacol Biochem Behav 1993;46:897-904.
27. Brailowsky S, Menini C, Silva-Barrat C, Naquet R: Epileptogenic γ-aminobutyric acid-withdrawal syndrome after chronic, intracortical infusion in baboons. Neurosci Lett 1987;74: 75-80.
28. Frye CA, Erskine MS: Influence of time of mating and paced copulation on induction of pseudopregnancy in cyclic female rats. J Reprod Fertil 1990;90:375-385.
29. Long JA, Evans HM: Oestrus cycle in the rat and its associated phenomena. Mem Univ Calif 1922;6:1-146.
30. Frye CA, Bock BC, Kanarek RB: Hormonal milieu affects tailflick latency in female rats and may be attenuated by access to sucrose. Physiol Behav 1992;52:699-706.
31. Purdy RH, Moore PH, Narasimha Roa P, Hagino N, Yamaguchi T, Schmidt P, Rubinow DR, Morrow AL, Paul SM: Radioimmunoassay of 3α-hydroxy-5α-pregnan-20-one in rat and human plasma. Steroids 1990;55:290-296.
32. Frye CA, Bayon LE, Pursnani NK, Purdy RH: Neurosteroids, P and 3α,5α-THP, enhance proceptivity, receptivity, and sexual motivation in female rats. Brain Res 1998;in press.
33. Rodbard D, Hutt DM: Statistical analysis of radioimmunoassay and immunoradiometric assays: A generalized, weighted interactive, least squares method for logistic curve fitting; in International Atomic Energy Agency (ed): Symposium on Radioimmunoassay and Related Procedures in Medicine. New York, Uniput, 1974.
34. Frye CA, McCormick CM, Coopersmith C, Erskine MS: Effects of paced and non-paced mating stimulation on plasma progesterone, 3α-diol and corticosterone. Psychoneuroendocrinology 1996;21:431-439.
35. Craig CR: Anticonvulsant activity of steroids: Separability of anticonvulsant from hormonal effects. J Pharmacol Exp Ther 1966;153:337-343.
36. Silva-Barrat C, Champagnat J, Brailowsky S, Menini C, Naquet R: Relationship between tolerance to GABA agonist and bursting properties in neocortical neurons during GABA-withdrawal syndrome. Brain Res 1989;498:289-298.
37. Holmes GL, Weber DA: The effect of progesterone on kindling: A developmental study. Dev Brain Res 1984;16:45-53.
38. Landgren S, Backstrom T, Kalistratov G: The effect of progesterone on the spontaneous interictal spike evoked by application of penicillin to the cat's cerebral cortex. J Neurol Sci 1978; 36:119-133.
39. Devaud LL, Purdy RH, Morrow AL: The neurosteroid, 3α-hydroxy-5α-pregnan-20-one, protects against bicuculline-induced seizures during ethanol withdrawal in rats. Alcohol Clin Exp Res 1995;19:350-355.
40. Kokate TG, Svensson BE, Rogawski MA: Anticonvulsant activity of neurosteroids: Correlation with γ-aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther 1994;270:1223-1229.
41. Frye CA, Scalise T, Bay on LE: Finasteride blocks the reduction in ictal activity produced by exogenous estrous cyclicity. J Neuroendocrinol 1998;10:291-296.
42. Luntz-Leybman V, Freund RK, Collins AC: 5α-Pregnan-3α-ol-20-one blocks nicotine-induced seizures and enhances paired-pulse inhibition. Eur J Pharmacol 1990;185:239-242.
43. Finn DA, Roberts AJ, Crabbe JC: Neuroactive steroid sensitivity in withdrawal seizure-prone and -resistant mice. Alcohol Clin Exp Res 1995;19:410-415.
44. Romeo E, Brancati A, De LA, Fucci P, Furnari C, Pompili E, Sasso GF, Spalletta G, Troisi A, Pasini A: Marked decrease of plasma neuroactive steroids during alcohol withdrawal. Clin Neuropharmacol 1996;19:366-369.
45. Zimmerberg B, Brunelli SA, Hofer MA: Reduction of rat pup ultrasonic vocalizations by the neuroactive steroid allopregnanolone. Pharmacol Biochem Behav 1994;47:735-738.
46. Zimmerberg B, McDonald BC: Prenatal alcohol exposure influences the effects of neuroactive steroids on separation-induced ultrasonic vocalizations in rat pups. Pharmacol Biochem Behav 1996;55:541-547.
47. Smith SS, Gong QH, Li X, Moran MH, Bitran D, Frye CA, Hsu FC: Withdrawal from 3-alpha-OH-5-alpha-pregnan-20-one using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha-4 subunit in association with increased anxiety. J Neurosci 1998;18:5275-5284.
48. A receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 1998;392:926-930.
49. Baulieu EE: Neurosteroids: A new function in the brain. Biol Cell 1991;71:3-10.
50. Schumacher M, Robel P, Bowlie EE: Development and regeneration of the nervous system: A role for neurosteroids. Dev Neurosci 1996; 18:6-21.